These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24819315)

  • 1. Effect of simvastatin treatment on plasma visfatin levels in obese women.
    Petreanu M; Eleuterio N; Bosco AA; Sandrim VC
    Gynecol Endocrinol; 2014 Aug; 30(8):577-80. PubMed ID: 24819315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
    De Luis DA; Conde R; Gonzalez Sagrado M; Aller R; Izaola O; Perez Castrillon JL; Romero E; Castro MJ
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):759-63. PubMed ID: 21061834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum visfatin levels in women with polycystic ovary syndrome.
    Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
    Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin concentrations in patients with endometrial cancer.
    Nergiz Avcioglu S; Altinkaya SO; Küçük M; Yüksel H; Ömürlü IK; Yanik S
    Gynecol Endocrinol; 2015 Mar; 31(3):202-7. PubMed ID: 25377860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body fat distribution has no effect on serum visfatin levels in healthy female subjects.
    Ersoy C; Sadikoglu G; Orhan H; Guclu M; Sarandol E; Akgun MD; Ozcakir A; Imamoglu S
    Cytokine; 2010 Mar; 49(3):275-8. PubMed ID: 20045351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exercise training on plasma visfatin and eotaxin levels.
    Choi KM; Kim JH; Cho GJ; Baik SH; Park HS; Kim SM
    Eur J Endocrinol; 2007 Oct; 157(4):437-42. PubMed ID: 17893257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
    Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.